A detailed history of Meritage Portfolio Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Meritage Portfolio Management holds 5,482 shares of BMY stock, worth $291,587. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,482
Previous 5,528 0.83%
Holding current value
$291,587
Previous $300,000 24.0%
% of portfolio
0.01%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $1,851 - $2,437
-46 Reduced 0.83%
5,482 $228,000
Q1 2024

Apr 29, 2024

SELL
$47.98 - $54.4 $468,572 - $531,270
-9,766 Reduced 63.86%
5,528 $300,000
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $2.61 Million - $3.12 Million
-53,868 Reduced 77.89%
15,294 $785,000
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $37,917 - $42,398
-655 Reduced 0.94%
69,162 $4.01 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $135,447 - $150,393
2,126 Added 3.14%
69,817 $4.47 Million
Q1 2023

Apr 25, 2023

BUY
$65.71 - $74.53 $1.83 Million - $2.07 Million
27,776 Added 69.59%
67,691 $4.69 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $88,202 - $104,443
1,288 Added 3.33%
39,915 $2.87 Million
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $249 - $147,225
1,916 Added 5.22%
38,627 $2.75 Million
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $3.15 Million - $3.47 Million
-43,371 Reduced 54.16%
36,711 $2.83 Million
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $62,832 - $75,341
1,022 Added 1.29%
80,082 $5.85 Million
Q4 2021

Jan 28, 2022

BUY
$53.63 - $62.52 $1.29 Million - $1.5 Million
24,009 Added 43.61%
79,060 $4.93 Million
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $8,047 - $9,426
-136 Reduced 0.25%
55,051 $3.26 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $16,963 - $18,473
274 Added 0.5%
55,187 $3.69 Million
Q1 2021

Apr 27, 2021

BUY
$59.34 - $66.74 $689,471 - $775,452
11,619 Added 26.84%
54,913 $3.47 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $113,805 - $128,962
1,971 Added 4.77%
43,294 $2.69 Million
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $176,137 - $195,183
-3,067 Reduced 6.91%
41,323 $2.49 Million
Q2 2020

Jul 27, 2020

SELL
$54.82 - $64.09 $231,614 - $270,780
-4,225 Reduced 8.69%
44,390 $2.61 Million
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $1.35 Million - $1.96 Million
-29,044 Reduced 37.4%
48,615 $2.71 Million
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $1.38 Million - $1.81 Million
-28,144 Reduced 26.6%
77,659 $4.99 Million
Q3 2019

Oct 25, 2019

BUY
$42.77 - $50.71 $90,116 - $106,845
2,107 Added 2.03%
105,803 $5.37 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $1.88 Million - $2.08 Million
42,058 Added 68.23%
103,696 $4.7 Million
Q1 2019

Apr 25, 2019

BUY
$45.12 - $53.8 $2.78 Million - $3.32 Million
61,638 New
61,638 $2.94 Million
Q4 2018

Jan 25, 2019

SELL
$48.76 - $63.23 $5.62 Million - $7.29 Million
-115,291 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$55.19 - $62.25 $88,469 - $99,786
-1,603 Reduced 1.37%
115,291 $7.16 Million
Q2 2018

Jul 25, 2018

BUY
$50.53 - $62.98 $1.11 Million - $1.39 Million
22,006 Added 23.19%
116,894 $6.47 Million
Q1 2018

Apr 26, 2018

SELL
$59.92 - $68.98 $24,267 - $27,936
-405 Reduced 0.43%
94,888 $6 Million
Q4 2017

Jan 29, 2018

BUY
$59.94 - $65.35 $5.71 Million - $6.23 Million
95,293
95,293 $5.84 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Meritage Portfolio Management Portfolio

Follow Meritage Portfolio Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Portfolio Management with notifications on news.